Plethysmographic Waveform for Monitoring the Quality of Cardiopulmonary Resuscitation (PWMQC)

April 27, 2015 updated by: Jun Xu

The Application Research of Plethysmographic Waveform in Quality Control Feedback System During Cardiopulmonary Resuscitation

Cardiopulmonary resuscitation(CPR) is the key to success for high-quality early cardiopulmonary resuscitation, and its success in the restoration of spontaneous circulation (ROSC), therefore, monitoring the quality of cardiopulmonary resuscitation and early identification ROSC is very important. Now there is no an easy, non-invasive and real-time method to monitor the quality of CPR. In this study the investigators hypothesis the pulse oximeter waveform can real-time monitor the quality of CPR ,and feedback the quality of CPR to the physicians.

Study Overview

Study Type

Observational

Enrollment (Actual)

617

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • PUMCH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

emergency room sample of multi-centers

Description

Inclusion Criteria:

  • cardiopulmonary arrest, without do-not-resuscitation(DNR) patients
  • After cardiac arrest, there is no more than 10 minutes until basic life support.
  • must be carried out advanced life support (tracheal intubation and end-tidal carbon dioxide monitoring)
  • comply with ethical requirements and signed informed consent

Exclusion Criteria:

  • DNR patients
  • rib fractures
  • hemorrhagic shock caused cardiac arrest
  • severe anemia, hemoglobin less than 7g/dl
  • tension pneumothorax without closed drainage
  • pulmonary embolism or pericardial tamponade caused cardiac arrest
  • onychomycosis
  • people who paint fingernails
  • clearly influential peripheral oximetry underlying diseases (such as Raynaud's phenomenon, vasculitis)
  • The study physicians believe there is any case is not suitable for inclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
survival rate
Time Frame: 4 weeks
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

November 5, 2013

First Submitted That Met QC Criteria

November 12, 2013

First Posted (Estimate)

November 19, 2013

Study Record Updates

Last Update Posted (Estimate)

April 29, 2015

Last Update Submitted That Met QC Criteria

April 27, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013S-512
  • 2011-4001-04 (Other Grant/Funding Number: CHRDS)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiopulmonary Resuscitation

3
Subscribe